Answers are grounded in this paper and cite their sources.
Computational toxicity modeling can have significant impact in the drug discovery process, especially when utilized as a sentinel filter for common drug safety liabilities, such as mutagenicity, carcinogenicity and teratogenicity. This review will focus on the strengths and limitations of the current computational models for predicting these drug safety liabilities, and the various strategies for incorporating these predictive models into the drug discovery process.
No takes yet. Share an insight, caveat, or question.
Pearl et al. (2001) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: